Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Stomach Neoplasms 1Metaplasia 1Lung Neoplasms 1Gastroesophageal Reflux 1Colitis 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1

Interventions

Erlotinib Hydrochloride 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Metaplasia × Endoscopy × Clear all
NCT04454476 2024-07-31

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting
15 enrolled
Gastrointestinal

Metaplasia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡